Prevalence and factors associated with hepatitis C among pregnant women in China: a cross-sectional study

Author:

He Sun,Shuang Gao,Yinglan Wu,Lan Wang,Wei Wang,Ailing Wang,Changhe Wang,Xiaoyan Wang,Qun Gao,Zechun Lu,Dongxu Huang,Yu Wang,Han Mo Phoenix Kit,Zhongdan Chen,Chan Polin,Qian Wang

Abstract

AbstractPregnant women infected with HCV should be given attention due to their special physiological stage and the effect on offspring health. To examine the prevalence of HCV infection among pregnant women in part of China and explore relevant factors during pregnancy, a cross-sectional study was conducted in four maternal and children health care institutions (MCHC) in Guangdong, Hunan and Chongqing. Pregnant women who were delivered, induced or spontaneous abortion were included and relevant information was collected through the Hospital Information System. Results showed that the prevalence of HCV among pregnant women in four MCHCs was 0.11% (95% CI 0.09–0.13%). Age, occupations, regions, syphilis-infection, intrahepatic cholestasis of pregnancy (ICP), and placenta previa were significant factors (all P < 0.05). Age and syphilis-infection were positively correlated with HCV infection (Z = 3.41, P = 0.0006; OR = 18.16, 95% CI 9.34–35.29). HCV and HBV infection were risk factors of ICP (OR = 4.18, 95% CI 2.18–8.04; OR = 2.59, 95% CI 2.31–2.89). Our study indicates that the prevalence of HCV among pregnant women in the three provinces(city) was low compared with the general population in China. Older age and syphilis-infection increased the risk of HCV infection during pregnancy. HCV infection was a risk factor of ICP. Generally, we need keep a watchful eye on HCV infection and relevant factors mentioned above during pregnancy in clinic, especially those also infected with syphilis. HCV testing based on risk factors is recommended in antenatal care and obstetrics.

Funder

world health organization

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference39 articles.

1. World Health, O. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2021: Accountability for the Global Health Sector Strategies 2016–2021: Actions for Impact. xii, 92 p. (World Health Organization, 2021).

2. Spera, A. M., Eldin, T. K., Tosone, G. & Orlando, R. Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?. World J. Hepatol. 8, 557–565. https://doi.org/10.4254/wjh.v8.i12.557 (2016).

3. Wang, W. Research progress on the latest transmission route and prevention of hepatitis C. Cap. Med. 28, 11–13. https://doi.org/10.3969/j.issn.1005-8257.2021.08.005 (2021).

4. Benova, L., Mohamoud, Y. A., Calvert, C. & Abu-Raddad, L. J. Vertical transmission of hepatitis C virus: Systematic review and meta-analysis. Clin. Infect. Dis. 59, 765–773. https://doi.org/10.1093/cid/ciu447 (2014).

5. Wen, Z. X., Zhu, P. & Wang, Y. M. Recent progress in clinical research of hepatitis C virus infection in pediatric patients. J. Clin. Hepatol. 2012, 888–892 (2012).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3